Mdxhealth to Release Third Quarter 2025 Financial Results on November 12

Rhea-AI Summary

MDxHealth (NASDAQ: MDXH) will release third quarter 2025 financial results for the period ended September 30, 2025 after market close on Wednesday, November 12, 2025.

The company will host a conference call and webcast with live Q&A on November 12, 2025 at 4:30 PM ET / 22:30 CET. Attendees are asked to access the webcast 15 minutes early. Dial-in numbers are provided for the United States, Belgium, the Netherlands, and the United Kingdom; the conference ID is 10203872. The live webcast URL is https://viavid.webcasts.com/starthere.jsp?ei=1738892&tp_key=76bbbf3f0a. A replay will be available on the company website following the call.

Mdxhealth to Release Third Quarter 2025 Financial Results
on November 12

Company to Host Conference Call with Live Q&A, November 12, 2025, at 4:30pm ET / 22:30 CET

IRVINE, California – November 3, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the third quarter ended September 30, 2025, after market close on Wednesday, November 12, 2025.

Title:	Mdxhealth Presents Third Quarter 2025 Financial Results and Corporate Update Conference Call and Webcast
Date:	November 12, 2025
Time:	4:30pm ET/ 22:30 CET
Conference Call Dial-in Details:	United States: 1-844-825-9789 Belgium: 0800 38 961 The Netherlands: 0800 94 94 506 United Kingdom: 0808 238 9064
Conference ID:	10203872
Webcast:	https://viavid.webcasts.com/starthere.jsp?ei=1738892&tp_key=76bbbf3f0a

The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.

About Mdxhealth

Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests are based on proprietary genomic, epigenomic, exosomal and other molecular signatures and assist physicians with the diagnosis and prognosis of prostate cancer and other urologic diseases. The Company’s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Waltham, Massachusetts and Plano, Texas. European headquarters are in Herstal, Belgium. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.

For more information: ir@mdxhealth.com LifeSci Advisors (IR & PR) John Fraunces Managing Director Tel: +1 917 355 2395 Jfraunces@lifesciadvisors.com

Attachment

• mdx11.25

FAQ

When will MDxHealth (MDXH) release third quarter 2025 results?

MDxHealth will release Q3 2025 results after market close on Wednesday, November 12, 2025.

What time is the MDxHealth (MDXH) Q3 2025 conference call and webcast?

The conference call and webcast are scheduled for November 12, 2025 at 4:30 PM ET / 22:30 CET with live Q&A.

How can investors join the MDxHealth (MDXH) webcast for the November 12, 2025 call?

Access the webcast at https://viavid.webcasts.com/starthere.jsp?ei=1738892&tp_key=76bbbf3f0a and join 15 minutes before the 4:30 PM ET start time.

What dial-in number and conference ID should I use for the MDxHealth (MDXH) November 12 call?

US dial-in: 1-844-825-9789; other country numbers listed for Belgium, Netherlands, UK; use Conference ID 10203872.

Will a replay be available after the MDxHealth (MDXH) November 12, 2025 webcast?

Yes. A replay of the webcast will be available on the company website after the live call concludes.